On November 25, 2021, five members of the inspection team of Gansu Provincial Drug Administration conducted on-site inspection and guidance on drug quality control and special drug risk control of Gansu puankang Pharmaceutical Co., Ltd., accompanied by members of the company's team at home.

At the special meeting, the inspection team first listened to the company's report on the implementation of the special work of special drug production and operation of the State Food and drug administration. Subsequently, he went to the front line to conduct on-site inspection on the allocation, storage, production and quality system of special drug products.

After the on-site inspection, the inspection team believes that the company can have responsibilities, measures and implementation in place in terms of special drug safety management and quality control. It is hoped that the company will continue to strictly implement the main responsibility for drug safety, pay close attention to the key links such as the import of raw and auxiliary materials, the production process and the delivery of finished products, strengthen the whole process control, strengthen the quality risk assessment, improve the quality awareness of all employees, and constantly improve the level of drug quality and safety control.